Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Københavns Universitets forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Profiler
Publikation
Forskningsenheder
Presse/medier
Aktiviteter
Priser
???studenttheses???
Forskningsdatasæt
Søg efter ekspertise, navn eller tilknytning
Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
Niklas W. Andersson, Henrik Svanstrom, Marie Lund, Bjorn Pasternak,
Mads Melbye
Institut for Klinisk Medicin
13
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Apixaban
100%
Clinical Practice
11%
Comparative Effectiveness
100%
Comparative Safety
100%
Confidence Interval
66%
Dabigatran
100%
Denmark
11%
Direct Oral Anticoagulants
33%
Effectiveness Outcomes
11%
Hazard Ratio
33%
Historical Cohort Study
11%
Major Bleeding
33%
Matched Comparison
22%
Nationwide Registers
11%
New User
11%
Non-valvular Atrial Fibrillation
100%
Once-daily
11%
Population-based
11%
Propensity Matching
22%
Propensity Score
11%
Rivaroxaban
100%
Routine Clinical Practice
11%
Safety Outcomes
11%
Stroke Risk
22%
Systemic Embolism
33%
Twice Daily
22%
Pharmacology, Toxicology and Pharmaceutical Science
Apixaban
100%
Atrial Fibrillation
100%
Bleeding
33%
Cerebrovascular Accident
33%
Cohort Study
11%
Dabigatran
100%
Direct Oral Anticoagulant
33%
Rivaroxaban
100%